Eeva Sievi

495 total citations
19 papers, 413 citations indexed

About

Eeva Sievi is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, Eeva Sievi has authored 19 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Physiology and 5 papers in Biochemistry. Recurrent topics in Eeva Sievi's work include Eicosanoids and Hypertension Pharmacology (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Eeva Sievi is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Eeva Sievi collaborates with scholars based in Finland, Hungary and Sweden. Eeva Sievi's co-authors include Marja Makarow, Heikki Vapaatalo, Frans M. Klis, Johan C. Kapteyn, H. van den Ende, Piet van Egmond, Tuula Lähteenmäki, Asko Riutta, Taina Suntio and E. Lunell and has published in prestigious journals such as FEBS Letters, Molecular Microbiology and British Journal of Pharmacology.

In The Last Decade

Eeva Sievi

19 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eeva Sievi Finland 11 240 78 77 58 54 19 413
Maizaton Atmadini Abdullah Malaysia 14 285 1.2× 52 0.7× 89 1.2× 40 0.7× 23 0.4× 36 662
Sheldon S. Hendler United States 12 274 1.1× 82 1.1× 27 0.4× 15 0.3× 35 0.6× 22 589
Xiaohui Qiu United States 12 274 1.1× 127 1.6× 48 0.6× 48 0.8× 89 1.6× 20 591
Xiaolei Li China 10 269 1.1× 114 1.5× 61 0.8× 23 0.4× 81 1.5× 22 474
Mehdi Imani Iran 13 227 0.9× 74 0.9× 41 0.5× 72 1.2× 20 0.4× 47 522
Yoshifumi Takatsume Japan 11 204 0.8× 65 0.8× 22 0.3× 27 0.5× 30 0.6× 30 377
Martina M.J. de Barse Netherlands 10 449 1.9× 70 0.9× 24 0.3× 22 0.4× 20 0.4× 11 681
Qinyuan Li China 8 214 0.9× 37 0.5× 65 0.8× 36 0.6× 15 0.3× 18 492
Ji Seon Lee South Korea 14 258 1.1× 42 0.5× 90 1.2× 35 0.6× 39 0.7× 23 475
Yong‐Jin Cho South Korea 9 169 0.7× 44 0.6× 38 0.5× 42 0.7× 47 0.9× 22 445

Countries citing papers authored by Eeva Sievi

Since Specialization
Citations

This map shows the geographic impact of Eeva Sievi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eeva Sievi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eeva Sievi more than expected).

Fields of papers citing papers by Eeva Sievi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eeva Sievi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eeva Sievi. The network helps show where Eeva Sievi may publish in the future.

Co-authorship network of co-authors of Eeva Sievi

This figure shows the co-authorship network connecting the top 25 collaborators of Eeva Sievi. A scholar is included among the top collaborators of Eeva Sievi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eeva Sievi. Eeva Sievi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Salo, Hanna, Eeva Sievi, Taina Suntio, et al.. (2004). Co-expression of two mammalian glycosyltransferases in the yeast cell wall allows synthesis of sLex. FEMS Yeast Research. 5(4-5). 341–350. 9 indexed citations
2.
Sievi, Eeva, Anna‐Liisa Hänninen, Hanna Salo, Vijay Kumar, & Marja Makarow. (2003). Validation of the Hsp150 Polypeptide Carrier and HSP150 Promoter in Expression of Rat α2,3-Sialyltransferase in Yeasts. Biotechnology Progress. 19(4). 1368–1371. 10 indexed citations
3.
Sievi, Eeva, Taina Suntio, & Marja Makarow. (2001). Proteolytic Function of GPI‐Anchored Plasma Membrane Protease Yps1p in the Yeast Vacuole and Golgi. Traffic. 2(12). 896–907. 28 indexed citations
4.
Riutta, Asko, Pauli Ylitalo, Markku Parviainen, et al.. (2000). Clinical pharmacology of eicosanoids, nicotine induced changes in man.. PubMed. 51(4 Pt 1). 631–42. 9 indexed citations
5.
Sievi, Eeva, et al.. (1999). Nicotinic Acid and Pyridoxine Modulate Arachidonic Acid Metabolism in vitro and ex vivo in Man. Pharmacology & Toxicology. 84(6). 274–280. 21 indexed citations
6.
Kapteyn, Johan C., Piet van Egmond, Eeva Sievi, et al.. (1999). The contribution of the O‐glycosylated protein Pir2p/Hsp150 to the construction of the yeast cell wall in wild‐type cells and β1,6‐glucan‐deficient mutants. Molecular Microbiology. 31(6). 1835–1844. 145 indexed citations
7.
Alanko, Juha, et al.. (1999). Amrinone, a Phosphodiesterase III Inhibitor, and Arachidonic Acid Metabolism in Humans. Journal of Cardiovascular Pharmacology. 33(1). 140–143. 2 indexed citations
8.
Sievi, Eeva, Jari Helin, Riikka Heikinheimo, & Marja Makarow. (1998). Glycan engineering of proteins with whole living yeast cells expressing rat liver α2,3‐sialytransferase in the porous cell wall. FEBS Letters. 441(2). 177–180. 8 indexed citations
9.
Alanko, Juha, et al.. (1998). Catechol estrogens as inhibitors of leukotriene synthesis. Biochemical Pharmacology. 55(1). 101–104. 13 indexed citations
10.
Sievi, Eeva, et al.. (1998). Nicotine stereoisomers and cotinine stimulate prostaglandin E2 but inhibit thromboxane B2 and leukotriene E4 synthesis in whole blood. European Journal of Pharmacology. 353(1). 87–92. 31 indexed citations
11.
Lähteenmäki, Tuula, Eeva Sievi, & Heikki Vapaatalo. (1998). Inhibitory effects of mesoionic 3‐aryl substituted oxatriazole‐5‐imine derivatives on vascular smooth muscle cell mitogenesis and proliferation in vitro. British Journal of Pharmacology. 125(2). 402–408. 13 indexed citations
12.
Korpela, Riitta, et al.. (1997). Lactobacillus rhamnosus GG shows antioxidative properties in vascular endothelial cell culture. Milk science international/Milchwissenschaft. 52(9). 503–505. 25 indexed citations
13.
Sievi, Eeva, et al.. (1997). Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.. PubMed. 47(10). 1093–8. 16 indexed citations
14.
Vaskonen, Timo, Juha Laakso, Eero Mervaala, Eeva Sievi, & Heikki Karppanen. (1996). Interrelationships between Salt and Fish Oil in Stroke-Prone Spontaneously Hypertensive Rat. Blood Pressure. 5(3). 178–189. 12 indexed citations
15.
Vanakoski, Jyrki, et al.. (1996). Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine*. Clinical Pharmacology & Therapeutics. 60(3). 308–315. 35 indexed citations
16.
Peuhkuri, Katri, et al.. (1996). Antioxidative Properties of Lactobacillus GG Measured as Prostacyclin and Nitric Oxide Production in Endothelial Cell Culture. Nutrition Today. 31(Supplement 1). 41S–41S. 17 indexed citations
17.
Lähteenmäki, Tuula, Eeva Sievi, & Heikki Vapaatalo. (1996). Antihypertensive Drugs Reduce Noradrenaline-induced Hypertrophy of Cultured Myocardial Cells. Journal of Pharmacy and Pharmacology. 48(3). 323–326. 4 indexed citations
18.
Sievi, Eeva, et al.. (1995). Efffects of NO-Donors, SIN-1 and GEA 3175 on Prostacyclin and cGMP Synthesis in Cultured Rat Endothelial Cells. Birkhäuser Basel eBooks. 45. 195–199. 5 indexed citations
19.
Riutta, Asko, et al.. (1994). Adrenaline infusion increases systemic prostacyclin production in man. Prostaglandins. 48(1). 43–51. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026